$GILD News and Market Events
Every $GILD story Market Flux has tracked.
- Last 7 days
- 1 story
- Previous 7 days
- 2 stories
- Latest story
- Related topics
- Healthcare
- Market Flux Event
AbbVie Lutikizumab Hits Primary Endpoint in Phase 3 Hidradenitis Suppurativa Trial
AbbVie's lutikizumab met its primary endpoint in a phase 3 clinical trial for hidradenitis suppurativa, a chronic and debilitating inflammatory skin disease, the company announced on…
- Top Mover
Eli Lilly Gains $40 Billion in Market Cap as Tech Selloff Drives Rotation Into Pharma
Eli Lilly shares climbed 3.59% on October 15, adding roughly $40 billion in market value and standing out as the single biggest gainer in a session that saw the broader U.S. market shed…
- Top Mover
Gilead Sciences Partners With Vir Biotechnology in Up-to-$1.9B Solid Tumor Cancer Deal
Gilead Sciences and Vir Biotechnology announced a multi-program collaboration and license agreement to discover and develop novel PRO-XTEN dual-masked T-cell engagers targeting solid…
- Market Flux Event
Vir Biotechnology and Gilead Strike Up-to-$1.9B Cancer Deal as Biotech Sector Sees Wave of Clinical and Deal Activity
Vir Biotechnology and Gilead Sciences announced a multi-program collaboration to discover and develop novel PRO-XTEN dual-masked T-cell engagers for solid tumors, with Vir receiving $90…
- Market Flux Event
Healthcare Conference Season Peaks With Dozens of Company Presentations as Biotech Names Draw Investor Scrutiny
Dozens of healthcare companies took the stage on September 9 at three major investor gatherings, the Wells Fargo 21st Annual Healthcare Conference, the Cantor Fitzgerald Global Healthcare…